Quansys Biosciences and non-profit health organisation PATH have developed a new multiplex diagnostic tool Q-Plex Micronutrient Array to fight against malnutrition and improve the health of women and children.

The new tool is designed to simultaneously detect up to seven nutrition-related biomarkers, as well as malaria infection in a single sample of human serum.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

The Q-Plex Micronutrient Array will enable researchers to compile national data on the status of micronutrient deficiency for implementing and assessing targeted interventions.

"The test gives researchers the ability to quantify key biomarkers for micronutrient deficiency and inflammation in a simple, single assay format."

Quansys Biosciences chief executive officer Matt Groll said: "We are proud to be a part of an exciting product that will make an impact in the world.

"The Q-Plex Micronutrient Array provides another great example of how public-private collaboration and the custom development and manufacture of quality products can improve health for women and children worldwide."

The results from the test can be utilised to determine the extent of the deficiency, identify sub-populations that are at greatest risk, and track the efficacy and progress of nutrition programmes.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

PATH senior research scientist David Boyle said: "The test gives researchers the ability to quantify key biomarkers for micronutrient deficiency and inflammation in a simple, single assay format.

"That will allow nutrition researchers and country health programme leaders to gather population data at the necessary scale-something that was highly challenging or impossible before."

Currently available in a 6-plex or 7-plex configuration, the customisable array can detect biomarkers that indicate deficiencies of iron and vitamin A, inflammatory status and malaria infection.

The seven panels present in the array identify ferritin, retinol binding protein 4, soluble transferrin receptor, C-reactive protein, thyroglobulin, alpha-acid glycoprotein and histidine-rich protein II.

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
Awarded for Innovation in Remote Hearing Diagnostics , hearX’s Self Test Kit (STK) delivers clinically validated audiometry via smart devices, enabling remote, scalable hearing assessments in homes, clinics and retail. Learn how hearX is redefining hearing care delivery and reducing costs for providers globally.

Discover the Impact